Global
中文
EN
About
Development milestones
Mission&Vision
Founder
Research Achievement
Technology Platforms
Single domain antibody
Five core technology platforms
Pipeline
Business cooperation
Product Out-Licensing
Co-Development
Career development
Our Story
Social Recruitment
News
Company News
Media
Contact Us
Company Address
Online Message
×
Home
中文
EN
About
About Novamab
Technology Platforms
Pipeline
Business cooperation
Market target layout
Strategic Cooperation
Career development
News
Company News
Media
Contact Us
About
Committed to the development
of innovative single domain antibody drugs
About Novamab
Scientific research papers
Up to now, the R&D team of Novamab Biology has published several research papers in influential journals.
2024-12-03
Efficient development of nanobody-based affinity chromatography for AAV8 purification.
Published on:
Protein Expression and Purification
More
2024-10-30
Ce-MOF@Au-Based Electrochemical Immunosensor for Apolipoprotein A1 Detection Using Nanobody Technology.
Published on:
ACS Applied Materials & Interfaces
More
2024-06-11
A novel inhalable nanobody targeting IL-4Rα for the treatment of asthma.
Published on:
J Allergy Clin Immunol.
More
2024-06-10
Nanobody-Based Microfluidic Immunosensor Chip Using Tetraphenylethylene-Derived Covalent Organic Frameworks as Aggregation-Induced Electrochemiluminescence Emitters for the Detection of Thymic Stromal Lymphopoietin.
Published on:
Analytical Chemistry
More
2024-05-16
A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer.
Published on:
Journal of Nanobiotechnology.
More
2024-02-16
High performance production process development and scale-up of ananti-TSLP nanobody
Published on:
Protein expression and purification, 218, 106441.
More
总计 24
1
2
3
4